<--- Back to Details
First PageDocument Content
Fixed dose combination / Gilead Sciences / Organofluorides / Non-nucleoside reverse transcriptase inhibitors / Bristol-Myers Squibb / Reverse-transcriptase inhibitor / ATC code J05 / Emtricitabine / Fixed-dose combination / Chemistry / Organic chemistry / Pharmacology
Date: 2015-03-19 15:53:21
Fixed dose combination
Gilead Sciences
Organofluorides
Non-nucleoside reverse transcriptase inhibitors
Bristol-Myers Squibb
Reverse-transcriptase inhibitor
ATC code J05
Emtricitabine
Fixed-dose combination
Chemistry
Organic chemistry
Pharmacology

STATE OF TENNESSEE DEPARTMENT OF HEALTH Ryan White Part B Program HIV DRUG ASSISTANCE PROGRAM (HDAP) FORMULARY

Add to Reading List

Source URL: health.tn.gov

Download Document from Source Website

File Size: 110,63 KB

Share Document on Facebook

Similar Documents

January 22, 2016  BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Gilead Sciences, Galapagos Close $2 Billion Deal for Anti­Infla

January 22, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Gilead Sciences, Galapagos Close $2 Billion Deal for Anti­Infla

DocID: 1rBxh - View Document

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

DocID: 1rqYi - View Document

March 4, 2016  BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

March 4, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

DocID: 1rdax - View Document

Microsoft Word - GILEAD BRIEFING

Microsoft Word - GILEAD BRIEFING

DocID: 1r2Vm - View Document

Patient Name:________________________________________ Date of Birth:__________________  Truvada® for Pre-Exposure Prophylaxis (PrEP) Medication Assistance Program Page 1 of 4

Patient Name:________________________________________ Date of Birth:__________________ Truvada® for Pre-Exposure Prophylaxis (PrEP) Medication Assistance Program Page 1 of 4

DocID: 1qMRc - View Document